Promising Data For Treating Gastrointestinal Cancer Leading To Hopeful Advancements For ...
Title: GOBLET platform study: Preliminary safety and tumor response results for the relapsed anal carcinoma cohort in patients treated with pelareorep and atezolizumab. Session Title: Poster Session C ...
TMCnet8 小时
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for ...
A recent report from MarketsAndMarkets projected that the global gastric cancer market accounted for USD 3.01 billion in 2023 and is expected to reach USD 18.43 billion by 2034 with a CAGR of 17.92% ...